GEHC financials
GE HealthCare Technologies Inc. · end-of-day data as of Oct 16, 2026
GE HealthCare Technologies Inc.
$69.57+14.8%
Buy · 21 analystsPT $83.63 +20.2%
GEHC reported revenue of $5.29B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 5.8% from a year earlier. It posted diluted EPS of $1.24, free cash flow of -$617M and a net margin of 10.8%.
Valuation
- P/E20.2x
- P/E vs own+3.0%
- P/E vs sector-28.4%
- FCF yield+2.8%
- Market cap$31.42B
Quarterly results
Q2 FY2026: Revenue +5.8% year over year, free cash flow -11.7% of revenue, operating margin 14.0%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $5.29B | 1.24 | -$617M | 41.2% | 14.0% | 10.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.13B | 0.85 | $112M | 38.5% | 10.0% | 7.6% |
| Q4 FY2025 | Dec 31, 2025 | $4.67B | 0.38 | $917M | 54.3% | 14.2% | 3.9% |
| Q3 FY2025 | Sep 30, 2025 | $5.14B | 0.98 | $483M | 38.7% | 12.7% | 8.7% |
| Q2 FY2025 | Jun 30, 2025 | $5.01B | 1.06 | $8M | 39.7% | 13.1% | 9.7% |
| Q1 FY2025 | Mar 31, 2025 | $4.78B | 1.23 | $98M | 42.1% | 13.2% | 11.8% |
| Q4 FY2024 | Dec 31, 2024 | $5.32B | 1.57 | $811M | 42.8% | 15.1% | 13.5% |
| Q3 FY2024 | Sep 30, 2024 | $4.86B | 1.02 | $648M | 41.7% | 13.9% | 9.7% |
| Q2 FY2024 | Jun 30, 2024 | $4.84B | 0.93 | -$183M | 41.4% | 12.6% | 8.8% |
| Q1 FY2024 | Mar 31, 2024 | $4.65B | 0.81 | $274M | 40.9% | 11.6% | 8.0% |
| Q4 FY2023 | Dec 31, 2023 | $5.21B | 0.88 | $956M | 41.4% | 13.2% | 7.7% |
| Q3 FY2023 | Sep 30, 2023 | $4.82B | 0.82 | $570M | 40.1% | 12.8% | 7.8% |